Cefixime for Oral Suspension USP 100 mg/5mL, 50mL HDPE bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc. Baltimore, Maryland, 21202 United States, Manufactured by: Lupin Limited, Manddeep, 462 046, India, NDC 68180-405-01
Published May 26, 2021 · Recall initiated: April 29, 2021
Summary
FDA records drug Class II recall D-0390-2021, published May 26, 2021 and initiated April 29, 2021. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 3,138 bottles; Lot: Lot #: F900787, Exp. Date 4/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug
What to do
Voluntary: Firm initiated · Letter
Get an email if CEFIXIME has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CEFIXIME
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- Nationwide within the United States
- UPC
- 0368180423089
- Lot
- Lot #: F900787, Exp. Date 4/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals,September 4, 2024
- FDACefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only,June 26, 2024
- FDACefixime for Oral Suspension 100mg/5mL, 50 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc.,February 7, 2024
- FDACefixime Capsules, 400 mg, 50-count bottles, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, India,January 12, 2022
- FDADelflex Peritoneal Dialysis Solution with 1.5% Dextrose, LM/LC, packaged in a case containing 2 x 6 LiterMay 26, 2021
- FDACequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mLMay 26, 2021
Questions about this recall
Was Cefixime for Oral Suspension USP 100 mg/5mL, 50mL HDPE bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc. Baltimore, Maryland, 21202 United States, Manufactured by: Lupin Limited, Manddeep, 462 046, India, NDC 68180-405-01 recalled?
Yes. FDA published recall D-0390-2021 on May 26, 2021. Reported hazard: Subpotent Drug
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CEFIXIME. UPC: 0368180423089.